Page last updated: 2024-10-29

ketoconazole and Bancroftian Elephantiasis

ketoconazole has been researched along with Bancroftian Elephantiasis in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"Tropical facial elephantiasis is a nosological entity which can arise from various underlying causes: von Recklinghausen neurofibromatosis, lymphatic and cutaneodermal filarioses, deep mycosis."1.34[A text-book case of tropical facial elephantiasis]. ( Dilu, NJ; Sokolo, R, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dilu, NJ1
Sokolo, R1

Other Studies

1 other study available for ketoconazole and Bancroftian Elephantiasis

ArticleYear
[A text-book case of tropical facial elephantiasis].
    Revue de stomatologie et de chirurgie maxillo-faciale, 2007, Volume: 108, Issue:1

    Topics: Adult; Antifungal Agents; Elephantiasis; Elephantiasis, Filarial; Face; Fatal Outcome; Filaricides;

2007